Craft

RedHawk Holdings Corp

Stock Price

$0

2023-11-16

Market Capitalization

$13.2 K

2023-11-16

Revenue

$129 K

FY, 2019

RedHawk Holdings Corp Summary

Company Summary

Overview
 RedHawk Holdings Corp is a diversified holding company which, through its subsidiaries, is engaged in sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. Through its medical products business unit, the Company sells WoundClot Surgical - Advanced Bleeding Control, the SANDD Insulin Needle Destruction Unit (formerly known as the Disintegrator). The Company's real estate leasing revenues are generated from a commercial property under a long-term lease. Additionally, the Company’s real estate investment unit holds limited liability company interest in a commercial restoration project in Hawaii.
Type
Public
Status
Active
HQ
Lafayette, LA, US | view all locations
Website
http://www.redhawkholdingscorp.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Lafayette, LA HQ

    United States

    100 Petroleum Dr #200

RedHawk Holdings Corp Financials

Summary Financials

Revenue (Q3, 2021)
$29.8K
Gross profit (Q3, 2021)
$24.1K
Net income (Q3, 2021)
($445.6K)
Cash (Q3, 2021)
$72.0K
EBIT (Q3, 2021)
($236.2K)
Enterprise value
$4.2M

Footer menu